carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten

C51H53F2N14O3W- — CID 159125851

IUPACcarbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten
SMILESCc1cc(F)c(C(=O)Nc2cccc(-c3nnc4n3CCCC4)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)O)cc1-n1cnc(C2CC2)c1.Nc1cccc(-c2nnc3n2CCCC3)n1.[CH3-].[W]
InChIInChI=1S/C25H24FN7O.C14H13FN2O2.C11H13N5.CH3.W/c1-15-11-18(26)17(12-21(15)32-13-20(27-14-32)16-8-9-16)25(34)29-22-6-4-5-19(28-22)24-31-30-23-7-2-3-10-33(23)24;1-8-4-11(15)10(14(18)19)5-13(8)17-6-12(16-7-17)9-2-3-9;12-9-5-3-4-8(13-9)11-15-14-10-6-1-2-7-16(10)11;;/h4-6,11-14,16H,2-3,7-10H2,1H3,(H,28,29,34);4-7,9H,2-3H2,1H3,(H,18,19);3-5H,1-2,6-7H2,(H2,12,13);1H3;/q;;;-1;
InChIKeyHSKKBRNRUIDNRF-UHFFFAOYSA-N
MW1131.92 g/mol
LogP9.04
Rot. Bonds9

About carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten

carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten (PubChem CID 159125851) has the molecular formula C51H53F2N14O3W- and a molecular weight of 1131.92 g/mol. Its IUPAC name is carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten.

Molecular Properties

Compound Namecarbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten
PubChem CID159125851
Molecular FormulaC51H53F2N14O3W-
Molecular Weight1131.92 g/mol
Exact Mass1131.39
IUPAC Namecarbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten
SMILESCc1cc(F)c(C(=O)Nc2cccc(-c3nnc4n3CCCC4)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)O)cc1-n1cnc(C2CC2)c1.Nc1cccc(-c2nnc3n2CCCC3)n1.[CH3-].[W]
InChIInChI=1S/C25H24FN7O.C14H13FN2O2.C11H13N5.CH3.W/c1-15-11-18(26)17(12-21(15)32-13-20(27-14-32)16-8-9-16)25(34)29-22-6-4-5-19(28-22)24-31-30-23-7-2-3-10-33(23)24;1-8-4-11(15)10(14(18)19)5-13(8)17-6-12(16-7-17)9-2-3-9;12-9-5-3-4-8(13-9)11-15-14-10-6-1-2-7-16(10)11;;/h4-6,11-14,16H,2-3,7-10H2,1H3,(H,28,29,34);4-7,9H,2-3H2,1H3,(H,18,19);3-5H,1-2,6-7H2,(H2,12,13);1H3;/q;;;-1;
InChIKeyHSKKBRNRUIDNRF-UHFFFAOYSA-N
XLogP9.04
TPSA215.26 Ų
H-Bond Donors3
H-Bond Acceptors15
Rotatable Bonds9
Heavy Atoms71
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001131.92
LogP ≤ 59.04
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten?
The IUPAC name of carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten (CID 159125851) is carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten.
What is the SMILES notation for carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten?
The canonical SMILES for carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten is Cc1cc(F)c(C(=O)Nc2cccc(-c3nnc4n3CCCC4)n2)cc1-n1cnc(C2CC2)c1.Cc1cc(F)c(C(=O)O)cc1-n1cnc(C2CC2)c1.Nc1cccc(-c2nnc3n2CCCC3)n1.[CH3-].[W].
What is the InChIKey of carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten?
The InChIKey is HSKKBRNRUIDNRF-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H24FN7O.C14H13FN2O2.C11H13N5.CH3.W/c1-15-11-18(26)17(12-21(15)32-13-20(27-14-32)16-8-9-16)25(34)29-22-6-4-5-19(28-22)24-31-30-23-7-2-3-10-33(23)24;1-8-4-11(15)10(14(18)19)5-13(8)17-6-12(16-7-17)9-2-3-9;12-9-5-3-4-8(13-9)11-15-14-10-6-1-2-7-16(10)11;;/h4-6,11-14,16H,2-3,7-10H2,1H3,(H,28,29,34);4-7,9H,2-3H2,1H3,(H,18,19);3-5H,1-2,6-7H2,(H2,12,13);1H3;/q;;;-1;.
What are the key properties of carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten?
carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten has a molecular weight of 1131.92 g/mol, XLogP of 9.04, 9 rotatable bonds, 3 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for carbanide;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methylbenzoic acid;5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-2-pyridinyl]benzamide;6-(5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)pyridin-2-amine;tungsten is sourced from PubChem (CID 159125851), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).